ガイドライン解説 AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease : 2011 update

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International review of thrombosis

• Publication date

  2012-12-01

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Beta-blockers for preventing stroke recurrence.

  2014cited by this paper
• The Importance of Population-Wide Sodium Reduction as a Means to Prevent Cardiovascular Disease and Stroke: A Call to Action From the American Heart Association

  2011cited by this paper
• AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.

  2011cited by this paper
• Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

  2011cited by this paper
• 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline)

  2011cited by this paper
• Eplerenone in patients with systolic heart failure and mild symptoms.

  2011cited by this paper
• 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2011cited by this paper
• Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association.

  2011cited by this paper
• Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association.

  2011cited by this paper
• Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College Of Cardiology Foundation.

  2010cited by this paper
• Home-based versus centre-based cardiac rehabilitation.

  2010cited by this paper
• A meta-analysis of randomized control trials of home-based secondary prevention programs for coronary artery disease

  2010cited by this paper
• Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease: A Meta-analysis of Randomized Trials

  2010cited by this paper
• Optimizing Statin Treatment for Primary Prevention of Coronary Artery Disease

  2010cited by this paper
• HEALTH and HUMAN SERVICES

  2010cited by this paper
• Relationship Between Cardiac Rehabilitation and Long-Term Risks of Death and Myocardial Infarction Among Elderly Medicare Beneficiaries

  2010cited by this paper
• Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.

  2010cited by this paper
• Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men

  2010cited by this paper
• Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.

  2010cited by this paper
• Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond

  2010cited by this paper
• Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.

  2009cited by this paper
• Intensive glucose control and macrovascular outcomes in type 2 diabetes

  2009cited by this paper
• Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk.

  2009cited by this paper
• Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

  2009cited by this paper
• Screening for depression in adults: U.S. preventive services task force recommendation statement.

  2009cited by this paper
• Routine screening for depression in patients with coronary heart disease never mind.

  2009cited by this paper
• A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2009cited by this paper
• Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding

  2009cited by this paper
• Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial.

  2009cited by this paper
• Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.

  2009cited by this paper
• Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease

  2009cited by this paper
• Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction

  2009cited by this paper
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

  2009cited by this paper
• Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.

  2009cited by this paper
• A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure.

  2009cited by this paper
• Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial.

  2009cited by this paper
• Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes

  2009cited by this paper
• Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

  2009cited by this paper
• Cytochrome p-450 polymorphisms and response to clopidogrel.

  2009cited by this paper
• Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension

  2008cited by this paper
• Cardiovascular outcomes in trials of oral diabetes medications: a systematic review.

  2008cited by this paper
• Effect on Cessation Counseling of Documenting Smoking Status as a Routine Vital Sign: An ACORN Study

  2008cited by this paper
• Depression screening and patient outcomes in cardiovascular care: a systematic review.

  2008cited by this paper
• Telmisartan, ramipril, or both in patients at high risk for vascular events.

  2008cited by this paper
• Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions.

  2008cited by this paper
• Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.

  2008cited by this paper
• Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study.

  2008cited by this paper
• Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.

  2008cited by this paper
• Telmisartan, ramipril, or both in patients at high risk for vascular events

  2008cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease

  2008cited by this paper
• Obesity, Behavioral Lifestyle Factors, and Risk of Acute Coronary Events

  2008cited by this paper
• Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.

  2007cited by this paper
• Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association.

  2007cited by this paper
• Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).

  2007cited by this paper
• Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.

  2007cited by this paper
• Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism.

  2007cited by this paper
• Prasugrel versus clopidogrel in patients with acute coronary syndromes.

  2007cited by this paper
• Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Pr

  2007cited by this paper
• AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services.

  2007cited by this paper
• Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double‐blind trial

  2007cited by this paper
• Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.

  2007cited by this paper
• Influenza Vaccination as Secondary Prevention for Cardiovascular Disease: A Science Advisory From the American Heart Association/American College of Cardiology

  2006cited by this paper
• ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography

  2006cited by this paper
• Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.

  2006cited by this paper
• Standards of medical care in diabetes.

  2006cited by this paper
• Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure.

  2006cited by this paper
• AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.

  2006cited by this paper
• Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy.

  2006cited by this paper
• Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

  2006cited by this paper
• Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Su

  2005cited by this paper
• Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

  2005cited by this paper
• Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.

  2005cited by this paper
• Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.

  2005cited by this paper
• Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials

  2005cited by this paper
• Meta-Analysis: Secondary Prevention Programs for Patients with Coronary Artery Disease

  2005cited by this paper
• Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.

  2005cited by this paper
• ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients Wi

  2004cited by this paper
• Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials.

  2004cited by this paper
• Angiotensin-converting-enzyme inhibition in stable coronary artery disease.

  2004cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2004cited by this paper
• Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)

  2004cited by this paper
• Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study.

  2004cited by this paper
• Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

  2004cited by this paper
• Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.

  2004cited by this paper
• Intensive versus moderate lipid lowering with statins after acute coronary syndromes [2] (multiple letters)

  2004cited by this paper
• Percutaneous Coronary Angioplasty Compared With Exercise Training in Patients With Stable Coronary Artery Disease: A Randomized Trial

  2004cited by this paper
• Clinical trials report

  2004cited by this paper
• Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

  2003cited by this paper
• Oral anticoagulants in patients with coronary artery disease.

  2003cited by this paper
• Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction

  2003cited by this paper
• Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

  2003cited by this paper
• A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.

  2003cited by this paper
• ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).

  2003cited by this paper
• EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION

  2003cited by this paper
• Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation.

  2003cited by this paper
• Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).

  2003cited by this paper
• Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Ph

  2003cited by this paper
• Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

  2003cited by this paper

• Cardiac Rehabilitation in a Tertiary Care Centre: Insights into Healthcare Professionals’ Knowledge, Attitudes and Referral Practices

  2026cites this paper
• Recurrent myocardial infarction and adherence to secondary prevention strategies among adults with coronary artery disease in rural Aluva, South India: a nested case–control study

  2025cites this paper
• Clinical Efficacy of Atorvastatin and PCSK9 Inhibitors in Patients With Borderline Coronary Lesions: An Intravascular Ultrasound Assessment

  2025cites this paper
• Beta-Blocker Therapy After Myocardial Infarction

  2025cites this paper
• Development and application of artificial intelligence follow-up system in patients with coronary heart disease

  2025cites this paper
• The mediating role of physical activity self-efficacy between knowledge, psychological factors, and early physical activity in elderly post-PCI patients: a cross-sectional study

  2025cites this paper
• An Australian experience of the Rapid Access Chest Pain Assessment Clinic

  2025cites this paper
• Perceptions and experiences of self-initiated discontinuation of home-based exercise rehabilitation in people with coronary artery disease.

  2025cites this paper
• From hospital to home: a comprehensive platform supporting cardiac rehabilitation post-revascularization

  2025cites this paper
• Infectious diseases, cardio-cerebrovascular health and vaccines: pathways to prevention

  2025cites this paper
• Global burden of atherosclerotic cardiovascular disease attributed to lifestyle and metabolic risks

  2025cites this paper
• Sol Anterior Mini Torakotomi ile Tam Koroner Revaskülarizasyon

  2025cites this paper
• Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation

  2024cites this paper
• Cognition of diet quality and dietary management in elderly patients with coronary and other atherosclerotic vascular disease in western China, a qualitative research study

  2024cites this paper
• Improving Cardiac Rehabilitation Referral Rates in Patients with Coronary Heart Disease from Diverse Communities Using an Electronic Order System

  2024cites this paper
• Trends in California Cardiovascular Disease Mortality: Sex-Race/Ethnicity Disparity and Income Inequality.

  2024cites this paper
• The Heterogeneous Influences of Online Health Information Seeking on Aspirin Use for Cardiovascular Disease Prevention

  2024cites this paper
• Impact of a patient-centered tool to reduce misconceptions about coronary artery disease and its treatment: The CAD roadmap

  2024cites this paper
• Stress and cardiovascular disease: an update

  2024cites this paper
• Association Between Cardiovascular Event Type and Smoking Cessation Rates Among Outpatients With Atherosclerotic Cardiovascular Disease: Insights From the NCDR PINNACLE Registry

  2024cites this paper
• Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation

  2024cites this paper
• 心脏康复对心肺运动阳性的高原非阻塞性冠状动脉疾病患者症状和生活质量的影响

  2024cites this paper
• Personalised oral dosage forms using an ultra-compact tablet press at the point of care.

  2024cites this paper
• 60-Year-Old Man With Acute-Onset Exertional Dyspnea.

  2024cites this paper
• Polypill Strategy in Secondary Cardiovascular Prevention

  2024cites this paper
• The Psychological Well-being Index and Quality of Life After a Cardiac Rehabilitation Program Based on Aerobic Training and Psychosocial Support.

  2024cites this paper
• Facilitators and barriers of initiation and maintenance of physical activity among people with coronary heart disease: a qualitative study

  2024cites this paper
• Effect of enhanced external counterpulsation on coronary microcirculation dysfunction (CMD) in patients with coronary artery disease (EECP-CMD II): study protocol of a single-centre, open-label, parallel group, randomised controlled trial

  2024cites this paper
• Comparative effectiveness of different interventions on adherence to exercise-based CR among patients after percutaneous coronary intervention: a network meta-analysis of randomized controlled trials

  2024cites this paper
• Healthcare service utilisation among adults with coronary artery disease in rural Aluva, South India: a community-based cross-sectional study

  2024cites this paper
• Effects of muscle strength training combined with aerobic training versus aerobic training alone on cardiovascular disease risk indicators in patients with coronary artery disease: a systematic review and meta-analysis of randomised clinical trials

  2024cites this paper
• A Sum Greater Than its Parts

  2024cites this paper
• Sex differences in secondary preventive follow-up after coronary heart events

  2023cites this paper
• Use of Optimal Medical Therapy in Patients with Cardiovascular Disease Undergoing Cardiac Rehabilitation.

  2023cites this paper
• Impact of controlled blood pressure and pulse rate at discharge on clinical outcomes in patients with ST-segment elevation myocardial infarction.

  2023cites this paper
• Prognostic value of high-sensitivity C-reactive protein in patients undergoing percutaneous coronary intervention with different glycemic metabolism status

  2023cites this paper
• Sex Differences in Pharmacotherapy and Long-Term Outcomes in Patients With Ischaemic Heart Disease and Comorbid Left Ventricular Dysfunction.

  2023cites this paper
• Association of Troponin T measurements with long-term outcomes in patients with coronary artery disease participating in a secondary prevention trial

  2023cites this paper
• Psychological Distress and the Risk of Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease

  2023cites this paper
• Redefining the Roles of Aspirin across the Spectrum of Cardiovascular Disease Prevention

  2023cites this paper
• Seguimiento de los pacientes con cardiopatía isquémica en Atención Primaria durante la pandemia por COVID-19

  2023cites this paper
• Fixed dose combination drugs for cardiovascular disease in a prolonged humanitarian crisis in Lebanon: an implementation study

  2023cites this paper
• Trends in Short‐, Intermediate‐, and Long‐Term Mortality Following Hospitalization for Myocardial Infarction Among Medicare Beneficiaries, 2008 to 2018

  2023cites this paper
• Age at cardiovascular disease onset, dementia risk, and the role of lifestyle factors

  2023cites this paper
• The Blurry Line Between Primary and Secondary Prevention: Should We Continue to Use These Terms?

  2023cites this paper
• A cross-sectional examination of post-myocardial infarction physical activity levels among US rural and urban residents: Findings from the 2017–2019 Behavioral Risk Factor Surveillance System

  2023cites this paper
• Assessment of redundant randomized clinical trials among patients with ST segment elevation myocardial infarction

  2023cites this paper
• Behaviour change techniques and intervention characteristics in digital cardiac rehabilitation: a systematic review and meta-analysis of randomised controlled trials

  2023influential citation
• Cost-Effectiveness of Clopidogrel vs Aspirin Monotherapy After Percutaneous Coronary Intervention

  2023cites this paper
• Does affirmative action reduce disparities in healthcare use by Indigenous peoples? Evidence from Australia's Indigenous Practice Incentives Program.

  2023cites this paper
• Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study

  2023cites this paper
• Effect of a mutual goal‐based continuous care program on self‐management behaviour and health outcomes in patients after percutaneous coronary intervention: A randomized controlled trial

  2023cites this paper
• Role of β-blockers in Preventing Heart Failure and Major Adverse Cardiac Events Post Myocardial Infarction

  2023cites this paper
• Bifidobacterium lactis Probio-M8 Adjuvant Treatment Confers Added Benefits to Patients with Coronary Artery Disease via Target Modulation of the Gut-Heart/-Brain Axes

  2022cites this paper
• Outpatient cardiac rehabilitation dose after acute coronary syndrome in a nationwide cohort

  2022cites this paper
• Racial Differences in Medication Utilization for Secondary Prevention of Cardiovascular Disease in Kidney Transplant Recipients: A Post Hoc Analysis of the FAVORIT Trial Cohort

  2022cites this paper
• The Implications of Vaccines in Older Populations

  2022cites this paper
• Effectiveness of micro-lecture based cardiac rehabilitation education on health status in individuals with coronary artery disease: A randomized clinical trial

  2022cites this paper
• Association of Cardiovascular Disease and Military Veteran Status With Impairments in Physical and Psychological Functioning: Retrospective Cross-Sectional Analysis of US National Survey Data

  2022cites this paper
• Depressive Symptoms After Acute Myocardial Infarction and Its Association With Low Functional Capacity and Physical Activity

  2022cites this paper
• Association between influenza vaccination, all-cause mortality and cardiovascular mortality: a protocol for a living systematic review and prospective meta-analysis

  2022cites this paper
• Influenza vaccination and stroke risk reduction.

  2022cites this paper
• Association of Medication Adherence With Health Outcomes in the ISCHEMIA Trial.

  2022cites this paper
• The impact of enteric coating of aspirin on aspirin responsiveness in patients with suspected or newly diagnosed ischemic stroke: prospective cohort study: results from the (ECASIS) study

  2022cites this paper
• ADHERENCE TO CARDIOVASCULAR REHABILITATION WITH THE USE OF EXERGAMING: A SYSTEMATIC REVIEW

  2022cites this paper
• Secular Trends in Risk Profiles Among Adults With Cardiovascular Disease in the United States.

  2022cites this paper
• Optimal cardiovascular medical therapy: current guidelines and new developments

  2022cites this paper
• The Effects of High-Intensity Interval Training on Exercise Capacity and Prognosis in Heart Failure and Coronary Artery Disease: A Systematic Review and Meta-Analysis

  2022cites this paper
• Use of Guideline-Based Therapy for Diabetes, Coronary Artery Disease, and Chronic Kidney Disease After Acute Kidney Injury: A Retrospective Observational Study

  2022cites this paper
• Sex-specific interventions to prevent and manage frailty.

  2022cites this paper
• Sustained Effects of Different Exercise Modalities on Physical and Mental Health in Patients With Coronary Artery Disease: A Randomized Clinical Trial.

  2022cites this paper
• Multi-Modality Imaging for Prevention of Coronary Artery Disease and Myocardial Infarction in the General Population: Ready for Prime Time?

  2022cites this paper
• Feasibility and impact of whole-body high-intensity interval training in patients with stable coronary artery disease: a randomised controlled trial

  2022cites this paper
• 2022 ACC Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: A Framework for Pragmatic, Patient-Centered Care: A Report of the American College of Cardiology Solution Set Oversight Committee.

  2022cites this paper
• Cardiovascular responses to high‐intensity stair climbing in individuals with coronary artery disease

  2022cites this paper
• Strongly increased risk of gastric and duodenal ulcers among new users of low‐dose aspirin: results from two large cohorts with new‐user design

  2022cites this paper
• Effect of Aspirin on CKD Progression in Older Adults: Secondary Analysis From the ASPREE Randomized Clinical Trial.

  2022cites this paper
• Evaluation of Telephone-Based Cardiac Rehabilitation Services Delivered to Adults 65 and Older During the Early Months of the COVID-19 Pandemic

  2022cites this paper
• Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies

  2022cites this paper
• Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017–2019

  2022cites this paper
• Trajectories of alcohol consumption up to 30 years before and after the diagnosis of cardiovascular diseases: a longitudinal case–control study of 12 502 participants

  2021cites this paper
• Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis

  2021cites this paper
• Long-term hospital-based secondary prevention of coronary artery disease: a randomized controlled trial

  2021cites this paper
• Building Capacity Through ICCPR Cardiovascular Rehabilitation Foundations Certification (CRFC)

  2021cites this paper
• Impact of Renal Insufficiency on Prognosis of Patients with Acute Coronary Syndrome

  2021cites this paper
• Validation of open-source step-counting algorithms for wrist-worn tri-axial accelerometers in cardiovascular patients.

  2021cites this paper
• The Experience of Taking Medication to Prevent a Further Heart Attack: An Interpretative Phenomenological Analysis

  2021cites this paper
• A phenomenological analysis of the experience of taking medication to prevent a further heart attack

  2021cites this paper
• A Checklist Approach for Enhanced Outpatient Guideline-Directed Management in the Secondary Prevention of Atherosclerotic Cardiovascular Disease

  2021cites this paper
• Primary and Secondary Prevention of CAD: A Review

  2021cites this paper
• Are primary care physicians aware of peripheral artery disease risk reduction and management in the Saudi healthcare transformation era? A health cluster observational study

  2021cites this paper
• Pearls of Exercise-based Cardiac Rehabilitation Frame in Post Coronary Artery Bypass Graft

  2021influential citation
• Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies

  2021cites this paper
• The association between influenza vaccination, all-cause mortality and cardiovascular mortality: a protocol for a living systematic review and prospective meta-analysis

  2021cites this paper
• Overview of Cardiac Rehabilitation and Current Situations in Korea

  2021cites this paper
• Interhospital and interindividual variability in secondary prevention: a comparison of outpatients with a history of chronic coronary syndrome versus outpatients with a history of acute coronary syndrome (the iASPIRE Study)

  2021cites this paper
• Patients with Diabetes Complicated by Peripheral Artery Disease: the Current State of Knowledge on Physiotherapy Interventions

  2021cites this paper
• Translation, Cross-Cultural Adaptation, and Psychometric Validation of the Chinese/Mandarin Cardiac Rehabilitation Barriers Scale (CRBS-C/M)

  2021cites this paper
• Impact of Renin‐Angiotensin System Blockers on Mortality in Veterans Undergoing Cardiac Surgery

  2021cites this paper
• Effects of Bilberry and Oat intake on lipids, inflammation and exercise capacity after Acute Myocardial Infarction (BIOAMI): study protocol for a randomized, double-blind, placebo-controlled trial

  2021cites this paper